Pharmaxis Ltd (AU:SNT) has released an update.
Syntara Limited reported a cash outflow from operating activities amounting to $4,236,000 for the current quarter, with a total year-to-date cash outflow of $14,323,000, despite customer receipts and R&D tax incentives. The company’s investing activities resulted in a net cash inflow of $892,000 this quarter, primarily due to proceeds from business disposals. Overall, the financial report highlights significant research and development expenses alongside staff and administrative costs.
For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.
